Adithya Balasubramanian1, Marie-Liesse Asselin-Labat2

  • 1Personalised Oncology Division, the Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia; Department of Medical Biology, the University of Melbourne, Parkville, VIC, Australia; Department of Medical Oncology, Monash Health, Melbourne, VIC, Australia; Department of Medical Oncology, the Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.

Cancer cell
|May 9, 2025
PubMed
概括

研究人员绘制了肺腺癌 (LUAD) 进展期间的免疫变化. 确定TIM-3为目标可以推进LUAD免疫预防策略.